MetaVia

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MetaVia and other ETFs, options, and stocks.

About MTVA

MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases. 

CEO
Hyung-Heon Kim
CEOHyung-Heon Kim
Employees
9
Employees9
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2014
Founded2014
Employees
9
Employees9

MTVA Key Statistics

Market cap
5.32M
Market cap5.32M
Price-Earnings ratio
-0.10
Price-Earnings ratio-0.10
Dividend yield
Dividend yield
Average volume
105.43K
Average volume105.43K
High today
$1.68
High today$1.68
Low today
$1.53
Low today$1.53
Open price
$1.61
Open price$1.61
Volume
612.92K
Volume612.92K
52 Week high
$23.10
52 Week high$23.10
52 Week low
$1.34
52 Week low$1.34

Stock Snapshot

As of today, MetaVia(MTVA) shares are valued at $1.61. The company's market cap stands at 5.32M, with a P/E ratio of -0.10.

On 2026-03-18, MetaVia(MTVA) stock traded between a low of $1.53 and a high of $1.68. Shares are currently priced at $1.61, which is +5.0% above the low and -4.4% below the high.

The MetaVia(MTVA)'s current trading volume is 612.92K, compared to an average daily volume of 105.43K.

During the past year, MetaVia(MTVA) stock moved between $1.34 at its lowest and $23.10 at its peak.

During the past year, MetaVia(MTVA) stock moved between $1.34 at its lowest and $23.10 at its peak.

MTVA News

TipRanks 2h
MetaVia Advances DA-1726 Obesity Drug into Phase 1 Part 3

The latest update is out from MetaVia ( (MTVA) ). On March 18, 2026, MetaVia Inc. announced that an Institutional Review Board at Clinical Pharmacology of Miam...

TipRanks 3h
MetaVia announces IRB at Clinical Pharmacology of Miami approved Phase 1 study

MetaVia (MTVA) announced that the Institutional Review Board, IRB, at Clinical Pharmacology of Miami has approved the Company’s Phase 1 Part 3 clinical trial of...

TipRanks 6d
MetaVia expands global patent protection for vanoglipel into 2035

MetaVia (MTVA) announced a comprehensive global intellectual property portfolio supporting vanoglipel, its novel, orally available G-protein-coupled receptor 11...

People also own

Based on the portfolios of people who own MTVA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.